期刊文献+

血管活性肠肽诱导裸鼠体内激素依赖性前列腺癌血管生成的研究 被引量:2

Hormone-dependent angiogenesis induced by vasoactive intestinal peptide in nude mouse prostate cancer LNCaP
原文传递
导出
摘要 目的 检测裸鼠体内激素依赖性前列腺癌(LNCaP)组织中的血管内皮生长因子(VEGF) mRNA含量和微血管密度(MVD),探讨血管活性肠肽(VIP)促血管生成作用的机制.方法 利用雄性小鼠建立经100 nmol/L VIP和未经VIP处理的LNCaP动物模型,前者为实验组,后者为对照组.于第8天和第15天测量移植瘤的体积,利用实时定量聚合酶链反应(Real-time PCR,SYBR染料法)检测移植瘤组织中的VEGF mRNA水平,利用CD34计算移植瘤组织中的MVD.结果 第8天和第15天裸鼠LNCaP移植瘤体积、VEGF mRNA含量、MVD实验组[(55.38±10.82)、(89.41±15.66) mm3;1.38±0.41、1.76 ±0.67;43.7±11.4、59.1±13.8]均大于对照组[(28.56 ±7.39)、(48.73±12.48) mm3;0.42 ±0.13、0.59 ±0.24;26.3 ±9.2、30.6± 10.5],差异均有统计学意义(P<0.05).结论 VIP对裸鼠LNCaP移植瘤生长起促进作用,可能与其促进肿瘤新生血管相关. Objective To explore the mechanism of vasoactive intestinal peptide (VIP) inducing angiogenesis by detecting the vascular endothelial growth factor (VEGF) mRNA content and microvessel density (MVD) in experimental prostate cancer in vivo.Methods Nude mice were subcutaneously injected with LNCaP prostate cancer cells.Cells were incubated for 1 h in the presence (experimental group) or absence (control group) of 100 nmol/L VIP for 1 h before xenograf.By measuring the transplanted tumor volume,real-time quantitative polymerase chain reaction (Real-time PCR) was used to detect VEGF mRNA,and CD34 was applied to calculate the MVD in the transplanted tumor tissue at 8th day and 15th day.Results The tumor volume,VEGF mRNA content and MVD in the experimental group [(55.38 ± 10.82),(89.41 ±15.66) mm3; 1.38±0.41,1.76 ±0.67; 43.7±11.4,59.1 ± 13.8] were significantly increased as compared with those in the control group [(28.56 ±7.39),(48.73 ± 12.48) mm3 ;0.42±0.13,0.59±0.24; 26.3 ±9.2,30.6±10.5; P<0.05].Conclusion This study indicatesVIP promotes the growth of LNCaP cells probably by inducing angiogenesis in vivo.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2014年第8期1772-1774,共3页 Chinese Journal of Experimental Surgery
基金 青岛市公共领域科技支撑计划资助项目(10-3-3-4-11-nsh)
关键词 前列腺癌 血管活性肠肽 血管内皮生长因子 微血管密度 Prostate carcinoma Vasoactive intestinal peptide Vascular endothelial growth factor Microvessel density
  • 相关文献

参考文献14

  • 1Schally AV,Comaru-Schally AM,Plonowski A,et al.Peptide analogs in the therapy of prostate cancer[J].Prostate,2000,45 (2):158-166.
  • 2Komuro H,Kaneko S,Kaneko M,et al.Expression of angiogenic factors and tumor progression in human neuroblastoma[J].J Cancer Res Clin Oncol,2001,127 (12):739-743.
  • 3Weidner N.Intratumor microvessel density as a prognostic factor in cancer[J].Am J Pathol,1995,147 (1):9-19.
  • 4Wilder RL.Neuroimmunoendocrinology of the rheumatic diseases:past,present,and future[J].Ann N Y Acad Sci,2002,966:13-19.
  • 5张延伦,王鹏,安刚,张钢,李墨农,王琳.血管活性肠肽在前列腺腺癌组织及细胞中的表达及临床意义[J].中华实验外科杂志,2012,29(9):1813-1815. 被引量:2
  • 6Fernández-Martínez AB,Bajo AM,Isabel Arenas M,et al.Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1[J].Cancer Lett,2010,299 (1):11-21.
  • 7Fernández-Martínez AB,Bajo AM,Sánchez-Chapado M,et al.Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells[J].Prostate,2009,69 (7):774-786.
  • 8Xie Y,Wolff DW,Lin MF,et al.Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells[J].Mol Pharmacol,2007,72(1):73-85.
  • 9Gutiérrez-Ca(n)as I,Rodrígnez-Henche N,Bola(n)os O,et al.VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal[J].Br J Pharmacol,2003,139 (5):1050-1058.
  • 10Moody TW,Hill JM,Jensen RT.VIP as atrophic factor in the CNS and cancer cells[J].Peptides,2003,24(1):163-177.

二级参考文献27

  • 1文澜,张琍,李国庆,曹建国,杨述之.罗格列酮联用维甲酸抗胃癌裸鼠移植瘤血管生成的研究[J].中华消化杂志,2006,26(10):670-674. 被引量:9
  • 2于成功.血管活性肠肽与消化系肿瘤[J].国外医学(消化系疾病分册),1996,16(4):209-211. 被引量:3
  • 3代祖建,涂远荣,李旭,林敏,赖繁彩,陈剑锋.手汗症患者胸交感神经节胆碱乙酰转移酶、血管活性肠肽的表达及意义[J].中华实验外科杂志,2007,24(8):1017-1018. 被引量:10
  • 4Garcia V,Garcia JM,Silva J,et al.Levels of VEGF-A mRNA in plasma from patients with colorectal carcinoma as possible surrogate marker of angiogenesis.J Cancer Res Clin Oncol,2008,134:1165-1171.
  • 5Wu J,Hansen JM,Hao L,et al.Retinoic acid stimulation of VEGF secretion from human endometrial stromal cells is mediated by production of reactive oxygen species.J Physiol,2011,589:863-875.
  • 6Zhang JP,Chen XY,Li JS.Effects of all-trans-retinoic on human gastric cancer cells BGC-823.J Dig Dis,2007,8:29-34.
  • 7Hameed DA,el-Metwally TH.The effectiveness of retinoic acid treatment in bladder cancer:impact on recurrence,survival and TGFalpha and VEGF as end-point biomarkers.Cancer Biol Ther,2008,7:92-100.
  • 8Weidner N.Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors.Breast Cancer Res Treat,1995,36:169-180.
  • 9Calvani M,Trisciuoglio D,Berganaschi C,et al.Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells.Cancer Res,2008,68:285-291.
  • 10Mobius C,Demuth C,Aigner T,et al.Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma.Eur J Surg Oncol,2007,33:1025-1029.

共引文献3

同被引文献3

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部